Free insulin-like growth factor I: Are we hunting a ghost?

Hormone Research

Volumn 55, Issue SUPPL. 2, 2001, Pages 84-93

  Bang, Peter ^a   Ahlsén, Maria ^a   Berg, Ulrika ^a   Carlsson Skwirut, Christine ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Assays; Bioavailability; Free dissociable insulin like growth factor I; Free insulin like growth factor I; Insulin like growth factor binding proteins; Insulin like growth factor I; Methodology; Serum

Indexed keywords

GLUCOSE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

BLOOD SAMPLING; BODY GROWTH; CALCULATION; CIRCULATION; CONFERENCE PAPER; GLUCOSE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; IN VITRO STUDY; MICRODIALYSIS; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; TARGET ORGAN; VALIDATION PROCESS;

BLOOD CHEMICAL ANALYSIS; ENDOCRINOLOGY; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MATHEMATICS; MICRODIALYSIS;

EID: 0035743506     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063482     Document Type: Conference Paper

References (42)

1. Insulin-like growth factors and their binding proteins: Biological actions
2. Insulin-like growth factor binding protein (IGFBP)-3-bound IGF-I and IGFBP-3-bound IGF-II in growth hormone deficiency
3. Insulin-like growth factor-binding protein from human plasma. Purification and characterization
4. Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. 1. Circulating forms in man
5. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6
6. Properties of glycosylated and non-glycosylated human recombinant IGF binding protein-3 (IGFBP-3)
7. Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3
8. Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins
9. Identification of the major cleavage site in IGFBP-3 in pregnancy serum enclosing known IGF and heparin binding domains
10. Inhibition of the insulin-like growth factor (IGF)-IGF-binding protein interaction
11. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
12. Measurement of free insulin-like growth factor I using immunoradiometric assay
13. Free insulin-like growth factors (IGF-I and IGF-II) in human serum
14. The somatomedin hypothesis: 2001
15. Metabolic functions of liver-derived (endocrine) insulin-like growth factor I
16. Plasma free insulin-like growth factor I concentrations in growth hormone deficiency in children and adolescents
17. Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity
18. Free insulin-like growth factor I (IGF-I) in healthy subjects: Relationship with IGF-binding proteins and insulin sensitivity
19. IGFBP-3 proteolysis and its role in glucose homeostasis
20. Insulin infusion increases levels of free IGF-I and IGFBP-3 proteolytic activity in patients after surgery
21. IGFBP-3 and IGFBP-5 association with endothelial cells: Role of C-terminal heparin binding domain
22. Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein 3
23. Human pregnancy serum contains at least two distinct proteolytic activities with the ability to degrade insulin-like growth factor binding protein 3
24. Processing of insulin-like growth factor I and II by capillary and large vessel endothelial cells
25. Tissue localization of perfused endothelial cell IGF binding protein is markedly altered by association with IGF-I
26. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart
27. Insulin-like growth factor I and II in healthy man. Estimations of half-lives and production rates
28. Valid measurements of total IGF concentrations in biological fluids. Recommendations from The 3rd International Symposium on Insulin-like Growth Factors, 1994
29. Comparison of free IGF-I levels by biosensor and immunoradiometric measurements
30. The effect of oral glucose on serum free insulin-like growth factor I and II in health adults
31. Circulating levels of free insulin-like growth factors in obese subjects: The impact of type 2 diabetes
32. Effects of short-term fasting on free/dissociable insulin-like growth factor I concentrations in normal human serum
33. The free form of insulin-like growth factor I increases in circulation during normal human pregnancy
34. Postoperative induction of insulin-like growth factor binding protein 3 proteolytic activity: Relation to insulin and insulin sensitivity
35. Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: The possible role of insulin-like growth factor-binding protein-3 proteolysis
36. The 'dawn phenomenon' in adolescents with insulin-dependent diabetes mellitus: Possible contribution of insulin-like growth factor binding protein-1
37. Role of IGF binding protein 1 in the dawn phenomenon and glycemic control in children and adolescents with IDDM
38. Diurnal variation of IGFBP-3 protease activity and free dissociable IGF-I in adolescent boys with type 1 diabetes mellitus
39. Measurement of interstitial insulin in human muscle